FCH
DXCM icon

Freestone Capital Holdings’s DexCom DXCM Stock Holding History

Freestone Capital Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-30,032
Closed -$2.02M – 571
2025
Q3 		$2.02M Buy
30,032
+209
+0.7% +$16.5K 0.06% 181
2025
Q2 		$2.6M Buy
29,823
+7,242
+32% +$568K 0.09% 147
2025
Q1 		$1.54M Sell
22,581
-199
-0.9% -$16.2K 0.06% 181
2024
Q4 		$1.77M Buy
22,780
+3,637
+19% +$269K 0.06% 169
2024
Q3 		$1.28M Buy
19,143
+4,024
+27% +$330K 0.04% 192
2024
Q2 		$1.71M Buy
15,119
+884
+6% +$112K 0.06% 172
2024
Q1 		$1.97M Buy
14,235
+630
+5% +$79.2K 0.07% 166
2023
Q4 		$1.69M Buy
13,605
+437
+3% +$44.6K 0.08% 169
2023
Q3 		$1.23M Buy
13,168
+2,985
+29% +$336K 0.07% 163
2023
Q2 		$1.31M Buy
10,183
+117
+1% +$14.2K 0.05% 170
2023
Q1 		$1.17M Sell
10,066
-100
-1% -$11.2K 0.05% 180
2022
Q4 		$1.15M Sell
10,166
-195
-2% -$21.4K 0.05% 181
2022
Q3 		$834K Sell
10,361
-619
-6% -$52.4K 0.04% 214
2022
Q2 		$818K Sell
10,980
-1,236
-10% -$113K 0.03% 222
2022
Q1 		$1.56M Buy
12,216
+5,340
+78% +$584K 0.06% 209
2021
Q4 		$923K Buy
6,876
+1,188
+21% +$171K 0.04% 241
2021
Q3 		$778K Buy
+5,688
New +$717K 0.04% 240
2021
Q1 		– Sell
-460
Closed -$42.5K – 581
2020
Q4 		$42.5K Buy
460
+224
+95% +$20K ﹤0.01% 604
2020
Q3 		$24.3K Buy
+236
New +$24.7K ﹤0.01% 613

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Freestone Capital Holdings's DXCM Position: Q4 2025 in Review

Freestone Capital Holdings sold out of DexCom (DXCM) in Q4 2025, closing a stake of 30,032 shares — an estimated $2.02M sold.

Freestone Capital Holdings first reported a position in DXCM in Q3 2020 and held it in 19 quarters. The position peaked at $2.6M in Q2 2025. 922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • Freestone Capital Holdings reported no remaining DexCom position as of Q4 2025 after selling out during the quarter.
  • Freestone Capital Holdings sold 30,032 DexCom shares in Q4 2025, an estimated $2.02M.
  • Freestone Capital Holdings first reported a position in DexCom in Q3 2020 and held it in 19 quarters.
  • Freestone Capital Holdings's DexCom position peaked at $2.6M in Q2 2025.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on Freestone Capital Holdings's 13F filing for Q4 2025, filed 23 Jan 2026.